FDA authorizes first dual glucose-ketone monitor for children as young as 2ByMorgan Ebert, Executive EditorAugust 25th 2026
Family history alone may not prompt type 1 diabetes screening, survey findsByMorgan Ebert, Executive EditorJuly 30th 2026
Tzield approved to preserve insulin production in children with newly diagnosed type 1 diabetesByMorgan Ebert, Executive EditorJune 15th 2026
ADA 2026 data highlight pediatric outcomes and treatment satisfaction with AfrezzaByMorgan Ebert, Executive Editor,Kevin Kaiserman, MDJune 11th 2026
Jamie Wood, MD, on the significance of the Afrezza approval for pediatric diabetesByJamie Wood, MDJune 4th 2026